Newswise — Jan. 10, 2020─Weight loss in obese patients with obstructive sleep apnea (OSA) appears to improve sleep apnea primarily by reducing tongue fat, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
In “Effect of Weight Loss on Upper Airway Anatomy and the Apnea Hypopnea Index: The Importance of Tongue Fat,” Richard J. Schwab, MD, and co-authors report on a study that used magnetic resonance imaging, or MRI, to measure the effect of weight loss on the pharyngeal structures surrounding the upper airway, which extends from the mouth to the larynx. The study is the first to show that weight loss reduces tongue fat in people with OSA.
Patients with OSA stop breathing repeatedly for short periods during sleep. Obesity is the primary risk factor for OSA, and previous studies have shown that decreases in body weight result in decreases in the Apnea/Hypopnea Index (AHI), a measure of how often a patient’s breathing stops completely or partially while sleeping.
In a previous study, Dr. Schwab, professor of medicine and chief of the Division of Sleep Medicine at the Perelman School of Medicine at the University of Pennsylvania, showed that tongue fat was increased in obese patients with sleep apnea compared to obese controls without sleep apnea. He conducted the present study “to determine if weight loss would decrease tongue fat and improve sleep apnea.”
The study included 67 participants with mild to severe OSA who were obese. Through diet or weight loss surgery, the patients lost nearly 10 percent of their body weight on average over six months. Overall, the participants’ AHI scores improved by 30.7 percent as measured by polysomnograpy, or sleep study.
The study found that reductions in tongue fat resulted in the greatest improvements in OSA. About 30 percent of the improvement was attributable to the changes in tongue fat, and the more weight a patient lost, the more tongue fat was reduced and the greater the improvement in OSA.
The study also found that weight loss resulted in reduced pterygoid (one of the jaw muscles that controls chewing) and pharyngeal lateral wall [muscles on the sides of the airway] volumes. Both these changes also improved OSA, but not to the same extent as reduced tongue fat. Weight loss was not associated with other upper airway changes.
The authors believe that their findings present a potential new therapeutic target for OSA: tongue fat. They suggest that future studies could be designed to explore whether certain low-fat diets are better than others in reducing tongue fat and whether cold therapies used to reduce stomach fat might be applied to reducing tongue size.
“Our study is the first to show that weight loss decreases tongue fat in patients with sleep apnea, which explains an important mechanism for the improvements in sleep apnea with reductions in weight,” Dr. Schwab said. “Our findings suggest a potential unique therapeutic target for patients with obesity and sleep apnea, i.e., reductions in tongue fat.”
This study was supported by the National Institutes of Health.
Contacts for Media
Richard J. Schwab, MD
Penn Medicine Communications
Share via Twitter
“Study finds that weight loss appears improve #obstructivesleepapnea, or #OSA, primarly by reducing tongue fat. @atscommunity @ATSBlueEditor @PennMedicine @PennMedNews”
About the American Journal of Respiratory and Critical Care Medicine
The AJRCCM is a peer-reviewed journal published by the American Thoracic Society. The Journal takes pride in publishing the most innovative science and the highest quality reviews, practice guidelines and statements in pulmonary, critical care and sleep medicine. With an impact factor of 16.494, it is one of the highest ranked journals in pulmonology. Editor: Jadwiga Wedzicha, MD, professor of respiratory medicine at the National Heart and Lung Institute (Royal Brompton Campus), Imperial College London, UK.
About the American Thoracic Society
Founded in 1905, the American Thoracic Society is the world's leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The Society’s 15,000 members prevent and fight respiratory disease around the globe through research, education, patient care and advocacy. The ATS publishes three journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology and the Annals of the American Thoracic Society.
The ATS will hold its 2020 International Conference, May 15-20, in Philadelphia, Pennsylvania, where world-renowned experts will share the latest scientific research and clinical advances in pulmonary, critical care and sleep medicine.